Hyperglycemia in Critically Ill Patients: Current Approaches and Management Strategies

Area of Science:

• Critical Care Medicine
• Endocrinology
• Medical Technology

Background:

• Hyperglycemia is common in critically ill patients, linked to higher morbidity and mortality.
• It can be pre-existing (diabetes mellitus) or develop as stress hyperglycemia during hospitalization.
• Effective management requires understanding pathophysiology, monitoring, and treatment protocols.

Purpose of the Study:

• To enhance medical staff awareness of hyperglycemia implications in critically ill patients.
• To review pathophysiology, monitoring techniques, and current treatment protocols.
• To highlight the importance of glycemic variability and individualized management.

Main Methods:

• Analysis of international literature from specialized journals.
• Focus on glycemic variability, individualized patient management, and emerging technologies.
• Review of monitoring techniques including continuous glucose monitoring and AI-enhanced biosensors.

Main Results:

• Hyperglycemia negatively impacts mortality via systemic damage and delayed detection.
• Recommended glycemic targets are 3.8-10.0 mmol/l (70-180 mg/dl) for variability and 6.1-10.0 mmol/l (110-180 mg/dl) for treatment.
• Intravenous insulin infusion is the primary treatment for hyperglycemic ICU patients.

Conclusions:

• Personalized glycemic control strategies are essential for improving patient outcomes in ICUs.
• Meticulous monitoring and timely interventions are necessary, especially for diabetic patients.
• Emerging technologies like AI-driven biosensors offer potential advancements in glucose monitoring.